← Back to Analyst Consensus 
CLYM Buy
Climb Bio, Inc.
Current Price —
Implied Upside —
Analysts 21
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 20, 2026 | Deutsche Bank | initiate | — → Buy | — | 57% |
| Sep 8, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Sep 8, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Sep 4, 2026 | B. Riley Securities | reiterate | Buy → Buy | — | 54% |
| Sep 3, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Sep 3, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Aug 24, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Aug 19, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Aug 7, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jul 27, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Jun 24, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jun 12, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Jun 11, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Jun 8, 2026 | Guggenheim | initiate | — → Buy | — | 52% |
| Jun 8, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| May 12, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| May 8, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| May 6, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| May 5, 2026 | Chardan Capital | initiate | — → Buy | — | 47% |
| Apr 21, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Apr 15, 2026 | Mizuho | initiate | — → Outperform | — | 52% |
| Apr 8, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Mar 24, 2026 | B. Riley Securities | initiate | — → Buy | — | 54% |
| Mar 18, 2026 | Truist Securities | initiate | — → Buy | — | 54% |
| Mar 11, 2026 | Raymond James | initiate | — → Strong Buy | — | 54% |
| Mar 10, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 6, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Mar 6, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Mar 5, 2026 | Wedbush | initiate | — → Outperform | — | 58% |
| Feb 13, 2026 | Piper Sandler | initiate | — → Overweight | $23 | 54% |
| Dec 30, 2025 | Freedom Broker | initiate | — → Buy | — | 59% |
| Dec 18, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $11 | 44% |
| Oct 16, 2025 | William Blair | initiate | — → Outperform | $0 | 48% |
| Oct 16, 2025 | BTIG | reiterate | Buy → Buy | $8 | 52% |
| Oct 13, 2025 | HC Wainwright & Co. | initiate | — → Buy | $9 | 44% |
| Sep 30, 2025 | BTIG | maintain | Buy → Buy | $8 | 52% |
| Sep 22, 2025 | BTIG | reiterate | Buy → Buy | $7 | 52% |
| Aug 15, 2025 | Baird | initiate | — → Outperform | $9 | 55% |
| Jun 6, 2025 | Oppenheimer | initiate | — → Outperform | $10 | 52% |
Price Target Trend
Jun 10, 2026 Oct 26, 2026
EPS Estimates
+1q —
+1y —
0y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days